Selegiline potentiates the effects of EGb 761 in response to ischemic brain injury

Neurochemistry International

Volumn 45, Issue 1, 2004, Pages 157-170

  Kwon, Y S ^a   Ann, H S ^b   Nabeshima, T ^c   Shin, E J ^a   Kim, W K ^d   Jhoo, J H ^e   Jhoo, W K ^a   Wie, M B ^a   Kim, Y S ^f   Jang, K J ^a   Kim, H C ^a  

^a Kangwon National University   (South Korea)

^b Dongduk Woman s University   (South Korea)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Ewha Womans University School of Medicine   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f Hallym University   (South Korea)

Author keywords

Antioxidant and neuroprotective effects; Behavioral effects; EGb 761; Gerbil; Ischemic reperfusion injury; Mitochondrial dysfunction; Selegiline

Indexed keywords

ALKENE DERIVATIVE; CARBONYL DERIVATIVE; GINKGO BILOBA EXTRACT; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MONOAMINE OXIDASE B INHIBITOR; REACTIVE OXYGEN METABOLITE; SELEGILINE; TRANSCRIPTION FACTOR FRA 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL LOSS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; GERBIL; HYPERACTIVITY; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SYNAPTOSOME;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DRUG SYNERGISM; GERBILLINAE; GINKGO BILOBA; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; SELEGILINE;

GERBILLINAE; GINKGO BILOBA;

EID: 11144356904     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2003.10.005     Document Type: Article

References (65)

1. Ahlemeyer B., Selke D., Schaper C., Klumpp S., Krieglstein J. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur. J. Pharmacol. 430:2001;1-7.
2. Akisu M., Kultursay N., Coker I., Huseyinov A. Plate activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Biol. Neonate. 74:1998;439-444.
3. Ann, H.S., Lee, J.M., Jang, K.J., Jhoo, W.K., Shin, E.J., Cheon, M.A., Lee, S.H., Kim, H.C., 1999. Selegiline enhances neuorprotective effects mediated by ginkgo biloba in global ischemia in gerbils. Soc. Neurosci. (abstr.) 29, 582.
4. Asano T.K., Takakura K., Suno H., Kikuchi H., Nageri I., Sato A., Tamura C., Ochial T., Sasaki T. Effetcs of hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurismal subarachnoid hemorrhage. Results of a multicenter, placebo-controlled double blind trial. J. Neurosurg. 84:1996;792-802.
5. Ballabriga J., Pellise A., Ferrer I. L-Deprenyl does not reduce brain damage in global forebrain ischemia in adult gerbils (Meriones ungiculatus). J. Neurol. Sci. 148:1997;1-5.
6. ++ in hippocampal neurons. Neuron. 9:1992;285-294.
7. Bruce-Keller A.J., Geddes J.W., Knapp P.E., McFall R.W., Keller J.N., Holtzberg F.W., Parthasarathy S., Steiner S.M., Mattson M.P. Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. J. Neuroimmunol. 93:1999;53-71.
8. Calapai G., Crupi A., Firenzuoli F., Marciano M.C., Squadrito F., Inferrera G., Parisi A., Rizzo A., Crisafulli C., Fiore A., Caputi A.P. Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci. 67:2000;2673-2683.
9. Carrillo M.C., Kitani K., Kansai S., Sato Y., Ivy G. The ability of (-)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region specific. Life Sci. 50:1992a;1985-1992.
10. Carrillo M.C., Kanai S., Ivy G., Sato Y., Kitani K. (-)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: the sex and age-related differences in the optimal dose in the rat. Exp. Neurol. 116:1992b;286-294.
11. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21:2001;2-14.
12. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate and neuronal degenerative disorders. Science. 262:1993;689-695.
13. Dubinsky J.M., Levi Y. Calcium-induced activation of the mitochondrial permeability transition in hippocampal neurons. J. Neurosci. Res. 53:1998;728-741.
14. Fischer M. Potentially effective therapies for acute ischemic stroke. Eur. J. Neurol. 35:1995;3-7.
15. Gray E.G., Whittaker V.P. The isolation of nerve endings from brain: an electron microscopic study of cell fragments derived by homogenation and centrifugation. J. Anat. 96:1962;79-88.
16. Grotta J. The current status of neuronal protective therapy: why have all neuronal protective drugs worked in animals but none so far in stroke patients? Cerebrovasc. Dis. 4:1994;115-120.
17. Harfstrand A., Fuxe K., Cintra A., Agnati L.F., Zini I., Wilkstrom A.C., Okret S., Zhao-Ying Y., Goldstein M., Steinbusch H., Verhofstad A., Gustafsson J.A. Glucocorticoid receptor immunoreactivity in monoaminergic neurons in rat brain. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9779-9783.
18. Hausen B.M. The sensitizing capacity of ginkgolic acids in guinea pigs. Am. J. Contact Dermatol. 9:1998;146-148.
19. Horn M., Schlotte W. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol. 85:1992;79-87.
20. Jhoo W.K., Shin E.J., Lee Y.H., Cheon M.A., Oh K.W., Kang S.Y., Lee C., Yi B.C., Kim H.C. Dual effects of dextromethorphan on cocaine-induced conditioned place preference in mice. Neurosci. Lett. 288:2000;76-80.
21. Kim H.C., Bing G., Jhoo W.K., Ko K.H., Kim W.K., Lee D.C., Shin E.J., Hong J.S. Dextromethorphan modulates the AP-1 DNA binding activity by kainic acid. Brain Res. 824:1999;125-132.
22. Kim H.C., Jhoo W.K., Bing G., Shin E.J., Wie M.B., Kim W.K., Ko K.H. Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Res. 874:2000a;15-23.
23. Kim H.C., Jhoo W.K., Kim W.K., Suh J.H., Shin E.J., Kato K., Ko K.H. An immunocytochemical study of mitochondrial manganese-superoxide dismutase in the rat hippocampus after kainate administration. Neurosci. Lett. 281:2000b;65-68.
24. Kim H.C., Bing G., Jhoo W.K., Kim W.K., Shin E.J., Park E.S., Choi Y.S., Lee D.W., Shin C.Y., Ryu J.R., Ko K.H. Oxidative damage causes formation of lipofuscin-like substances in the hippocampus of the senescence-accelerated mouse after kainate treatment. Behav. Brain Res. 131:2002a;211-220.
25. Kim H.C., Bing G., Kim S.J., Jhoo W.K., Shin E.J., Wie M.B., Ko K.H., Kim W.K., Flanders K.C., Choi S.G., Hong J.S. Kainate treatment alters TGF-β3 gene expression in the rat hippocampus. Mol. Brain Res. 108:2002b;60-70.
26. Kim H.C., Yamada K., Olariu A., Tran M.H., Mizuno M., Nakajima A., Nagai T., Jhoo W.K., Im D.H., Shin E.J., Park S.C., Kato K., Hjelle O.P., Ottersen O.P., Mirault M.E., Nabeshima T. Immunocytochemical evidence that β-amyloid (1-42) impairs endogenous antioxidant systems in vivo. Neuroscience. 119:2003;399-419.
27. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
28. Kita T., Paku S., Takehashi M., Kubo K., Wagner G.C., Nakashima T. Methamphtamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice. Neuropharmacology. 37:1998;1177-1184.
29. Klein J., Chatterjee S.S., Loffelholz K. Phospholipid breakdown and choline release under hypoxic conditions: inhibition by biobalide, a constituent of Ginkgo biloba. Brain Res. 755:1997;347-350.
30. Knoll J. The pharmacology of (-)deprenyl. J. Neural Transm. Suppl. 22:1986;75-89.
31. Koch E., Jaggy H., Chatterjee S.S. Evidence for immunotoxic effects of crude Ginkgo biloba L. leaf extracts using the popliteal lymph node assay in the mouse. Int. J. Immunopharmacol. 22:2000;229-236.
32. Kurobe N., Suzuki F., Kato K., Sato T. Sensitive immunoassay of rat superoxide dismutase: concentration in the brain, liver, and kidney are not affected by aging. Biomed. Res. 11:1990;187-194.
33. Lahtinen H., Koistinaho J., Kauppinen R., Haapalinna A., Kainanen R., Sivenius J. Selegiline treatment after transient global ischemia in gerbils enhances the survival of CA1 pyramidal cells in the hippocampus. Brain Res. 757:1997;260-267.
34. Lebel C.P., Bondy S.C. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem. Int. 17:1990;961-966.
35. Maclennan K.M., Darlington C.L., Smith P.F. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog. Neurobiol. 67:2002;235-257.
36. Mattson M.P., Keller J.N., Begley J.G. Evidenec for synaptic apoptosis. Exp. Neurol. 153:1998;35-48.
37. Melega W.P., Cho A.K., Schmitz D., Kuczenski R., Segal D.S. L-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine. J. Pharmacol. Exp. Ther. 288:1999;752-758.
38. Morimoto T., Mordecai Y.T., Busto R., Martinez E., Gindberg M.D. Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16:1996;92-99.
39. Oh S.M., Betz A.L. Interaction between free radicals and excitatory amino acids in formation of ischemic brain edema in rats. Stroke. 22:1991;915-921.
40. Oliver C.N., Ahn B.W., Moerman E.J., Goldstein S., Statman E.R. Age-related changes in oxidized proteins. J. Biol. Chem. 262:1987;5488-5491.
41. 2+-loded brain neurons. Brain Res. 635:1994;125-129.
42. Pahlmark K., Siesjo B.K. Effects of spin trap L-phenyl-N-tert-butyl nitrone (PBN) in transient forebrain ischemia in the rat. Acta Phys. Scand. 157:1996;41-52.
43. Pennypacker K.R., Hong J.S., McMillian M.K. Implications of prolonged expression of Fos-related antigens. Trends Pharmacol. Sci. 16:1995;317-321.
44. Petito C.K., Feldmann E., Pulsinelli W.A., Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology. 37:1987;1281-1286.
45. Prehn J.H. Mitochondrial transmembrane potential and free radical production in excitotoxic neurodegeneration. Naunyn Schmiedebergs Arch. Pharmacol. 357:1998;316-322.
46. 2+ homeostasis and respiration. Biosci. Report. 17:1997;53-66.
47. Rivet J.M., Stinus L., Le Moal M., Mormrde P. Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res. 498:1989;149-153.
48. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor: still lethal after eight years. Trends Neurosci. 18:1995;57-58.
49. Scremin O.U., Jenden D.J. Focal ischemia enhances choline output and decreases acetylcholine output from the rat cerebral cortex. Stroke. 20:1989;92-95.
50. Semkova I., Wolz P., Schilling M., Krieglstein J. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur. J. Pharmacol. 315:1996;19-30.
51. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
52. Spinnewyn B., Blavet N., Clostre F. Effects of Ginkgo biloba extract on a cerebral ischemia model in gerbils. Presse Medicale. 15:1986;1511-1515.
53. Stout A.K., Raphael H.M., Kabterewucz B.I., Klann E., Reynolds I.J. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1:1998;366-373.
54. Tatton W.G., Wadia J.S., Ju W.Y., Chalmers-Redman R.M., Tatton N.A. (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase. J. Neural Transm. Suppl. 48. 1996;45-59.
55. Trovero F., Brochet D., Tassin J.P., Drieu K. Ginkgo biloba extract reduces the development of amphetamine-induced behavioral sensitization: effects of hippocampal type II corticosteroid receptors. Brain Res. 818:1999;135-139.
56. Weichel O., Hilgert M., Chatterjee S.S., Lehr M., Klein J. Biloba, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus. Arch. Pharmacol. 360:1999;609-615.
57. Whittaker V.P., Michaelson I.A., Kirkland R.J. The separation of synaptic vesicles from nerve-ending particles ("synaptosomes"). Biochem. J. 90:1964;293-303.
58. Won M.H., Lee J.C., Kim Y.H., Song D.K., Suh H.W., Oh Y.S., Kim J.H., Shin T.K., Lee Y.J., Wie M.B. Postischemic hypothermia induced by eugenol protects hippocampal neurons from global ischemia in gerbils. Nuerosci. Lett. 254:1998;101-104.
59. Wu W.R., Zhu X.Z. The amphetamine-like reinforcing effect and mechanism of L-deprenyl on conditioned place preference in mice. Eur. J. Pharmacol. 364:1999;1-6.
60. Xiong Y., Gu Q., Peterson P.L., Muizelaar J.P., Lee C.P. Mitochondrial dysfunction and calcium pertubation induced by traumatic brain injury. J. Neurotrauma. 14:1997;23-34.
61. Yamaguchi S., Ogata H., Hamaguchi S., Kitajima T. Superoxide radical generation and histopathological changes in hippocampal CA1 after ischemia/reperfusion in gerbils. Can. J. Anesth. 45:1998;226-232.
62. Yamaguchi S., Hamagychi S., Mishio M., Okuda Y., Kitajima T. Propofol prevents lipid peroxidation following transient forebrain ischemia in gerbils. Can. J. Anesth. 47:2000;1025-1030.
63. Yasar S., Bergman J. Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies. Clin. Pharmacol. Ther. 56:1994;768-773.
64. Young S.T., Porrino L.J., Iadarola M.J. Cocaine induces c-Fos immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. U.S.A. 88:1991;1291-1295.
65. Zhang W.R., Hayashi T., Kitagawa H., Sasaki C., Warita H., Wang J.M., Shiro Y., Uchida M., Abe K. Protective effects of ginkgo extract on rat brain with transient cerebral artery occlusion. Neurol. Res. 22:2000;517-521.